TELA Bio Reports Increased Q1 Net Loss, Negative Equity, and High Cash Burn Amid Nasdaq Delisting Concerns
TELA sits 92% above its 52-week low of $0.501.
Summary
TELA Bio reported a larger net loss and increased cash burn in Q1 2026, leading to negative stockholders' equity, intensifying financial distress as the company navigates a Nasdaq delisting notice and plans for further share issuance.
Key Events · Earnings and Guidance · TELA
-
Increased Net Loss
Net loss for Q1 2026 increased to $12.3 million, up from $11.3 million in Q1 2025, reflecting continued operational challenges.
-
Negative Stockholders' Equity
Total stockholders' equity turned negative, reaching a deficit of $5.2 million as of March 31, 2026, a significant decline from $6.3 million in positive equity at year-end 2025.
-
High Operating Cash Burn
Cash used in operating activities rose to $11.2 million in Q1 2026, compared to $9.7 million in the prior year, indicating an accelerating cash burn rate.
-
Modest Revenue Growth
Revenue grew by a modest 3% to $19.1 million in Q1 2026 from $18.5 million in Q1 2025, primarily driven by international sales but offset by U.S. price mix headwinds.
Analysis · TELA · Industrial Applications And Services
TELA Bio's first-quarter 2026 results reveal a worsening financial position, with the company reporting a net loss of $12.3 million, an increase from $11.3 million in the prior year. Critically, the company's total stockholders' equity has turned negative, reaching a deficit of $5.2 million, down from a positive $6.3 million at the end of 2025. Operating cash burn also intensified, with $11.2 million used in Q1 2026 compared to $9.7 million in Q1 2025. This financial deterioration occurs while the company is already facing a Nasdaq deficiency letter for failing to meet the minimum bid price requirement. The company also disclosed a board-approved proposal to increase its equity incentive plan by 3.5 million shares, subject to shareholder approval in June, indicating further potential dilution as it seeks to manage its liquidity and operational challenges.
How filings like this one have moved
In the 30 days to Oct 15, 2026, 45.4% of the 295 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.48%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TELA was trading at $0.96 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $43M. The 52-week trading range was $0.50 to $2.20. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.